On June 12, 2020, Glaucoma Research Foundation presented an Innovations in Glaucoma Webinar, “What’s New in Glaucoma Medications?”
The recorded webinar features a discussion with glaucoma specialist David Richardson, MD (San Marino Eye) and Thomas Brunner (President and CEO, Glaucoma Research Foundation).
Dr. Richardson discusses existing and new medications for treating glaucoma and provide answers to frequently asked questions about glaucoma eye drops. Learn how the new medications are different from existing treatments, and about their potential side effects in this recorded webinar.
Tom Brunner: Good afternoon. My name is Tom Brunner, and I am the president and CEO of Glaucoma Research Foundation. Welcome to our webinar: What’s New in Glaucoma Medications? Today, we will learn about current and new medication options to treat glaucoma. Dr. David Richardson has very kindly agreed to join me today to talk about glaucoma treatment options, and we’ll try to answer as many of your questions as possible.
David is a glaucoma specialist and medical director at San Marino Eye in Southern California. He went to Harvard Medical School in Boston and did his ophthalmology residency at University of Southern California, Doheny Eye Institute. David is also an attending ophthalmologist at the Veterans Health Administration in Los Angeles and one of our newest Ambassadors for Glaucoma Research Foundation. It is my honor to welcome Dr. David Richardson.
David Richardson, MD: Welcome everyone. And hopefully this will be an informative hour for you. So let’s go ahead and get started. Now, before I go over the medical treatment of glaucoma, I think it’s important to take a couple of minutes just to introduce intraocular pressure and aqueous fluid, because these are intimately related to what we’re going to be talking about.
If we look at this schematic of an eye, we can see the front of the eye here with the cornea, the iris. Light is focused through the lens, back to the retina and the signal is then sent out to the brain through the optic nerve (#15 here). Now, the optic nerve is what’s damaged in glaucoma, and that damage is often related to elevated pressure. So let’s talk about pressure. The pressure in the eye is important in that you need some pressure to keep the eye round just like you need pressure to keep a ball round.
Full Transcript at: GLAUCOMA RESEARCH FOUNDATION.
David Richardson, MD
Medical Director, San Marino Eye
David Richardson, M.D. is recognized as one of the top cataract and glaucoma surgeons in the US and is among an elite group of glaucoma surgeons in the country performing the highly specialized canaloplasty procedure. Morever, Dr. Richardson is one of only a few surgeons in the greater Los Angeles area that performs MicroPulse P3™ "Cyclophotocoagulation" (MP3) glaucoma laser surgery. Dr. Richardson graduated Magna Cum Laude from the University of Southern California and earned his Medical Degree from Harvard Medical School. He completed his ophthalmology residency at the LAC+USC Medical Center/ Doheny Eye Institute. Dr. Richardson is also an Ambassador of Glaucoma Research Foundation.